Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-06-13 to 2023-06-14
Current total value of award: $1785.6
Description: 4561256220!ORALAIR 300 IR SUBLINGUAL TAB 30S